Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1234630

registered interest
date	15/09/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sepsis: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what funding the Government is allocating from the public purse to develop new sepsis diagnostics to determine whether a patient with sepsis has a bacterial or viral infection.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	90187
answer	answer is ministerial correction date of answer 29/09/2020 answer text <p>Developing new diagnostics that enable early detection of bacterial or viral infections and drive optimal antimicrobial usage is a priority for this Government. Since 2014, the Government has invested over £360 million in antimicrobial resistance research and development, including funding to support the development of diagnostics for infection.</p><p>Investments in early-stage funding for diagnostic research include the £10 million Longitude Prize for a diagnostic tool that can rule out antibiotic use or help identify an effective antibiotic to treat a patient. The National Institute for Health Research Medtech and In Vitro Diagnostic Co-operatives support the development of medical technology and the uptake of commercially supplied in vitro diagnostic devices, including for infection-related tests. The £14.25 million award is for five years until 2022.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 29/09/2020 08:48:42 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4474 label Biography information for Kevin Hollinrake

1186650

registered interest
date	19/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antibiotics: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle the rise of carbapenem-resistant bacteria in secondary care.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	32282
answer	answer is ministerial correction date of answer 27/04/2020 answer text <p>Carbapenemase-producing Enterobacteriaceae (CPE) are carbapenem-resistant infections with the ability to transfer resistance to different bacterial species. Public Health England conducts monitoring and surveillance of these infections and publishes toolkits to support acute and non-acute organisations to prevent and control the spread of CPE.</p><p>The Government recognises that identifying where carbapenemase-producing Gram-negative infections occur, and acting to prevent them, is essential to maintain the effectiveness of our most important antibiotics. Work is underway to add these infections to the list of notifiable diseases as part of our national action plan for antimicrobial resistance.</p><p>NHS England and NHS Improvement continues to work to reduce the burden of all healthcare-associated infections and is tasked with delivering the Government’s ambition to halve all healthcare associated Gram-negative blood stream infections by 2023-24.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/04/2020 13:08:29 answering member 4380 label Biography information for Jo Churchill
tabling member	4474 label Biography information for Kevin Hollinrake

1132766

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	What steps he is taking to improve social care.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	911424
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>Local authorities have a duty to ensure people receive appropriate care and support. We have given them access to up to £3.9 billion more dedicated funding for adult social care this year, and a further £410 million has been made available for adult and children’s services.</p><p>We will set out our plans to reform the social care system at the earliest opportunity to ensure it is sustainable for the future.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 18/06/2019 15:02:18 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4474 label Biography information for Kevin Hollinrake

997217

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 March 2018 to Question 132264 on Antibiotics: Drug Resistance, whether his Department has made an assessment of the potential merits of including (a) the latest electronic technology to reduce hospital infections and (b) other best practice on hand hygiene compliance in the prevention strand of the new antimicrobial resistance strategy.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	185000
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Infection prevention and control will remain a key pillar of the United Kingdom’s upcoming five-year national action plan on antimicrobial resistance.</p><p> </p><p>NHS Improvement, who lead on infection prevention and control, has included a hand hygiene monitoring and compliance workstream in its current work programme.</p><p> </p><p>NHS Improvement has undertaken a rapid review of evidence on the use of electronic monitoring devices across the National Health Service to determine hand hygiene compliance. The technology used in some trusts is currently reliant on local data infrastructure and many existing systems would not be able to support it.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:31:20 answering member 4067 label Biography information for Steve Brine
tabling member	4474 label Biography information for Kevin Hollinrake